584 related articles for article (PubMed ID: 22069233)
1. 3D calculation of absorbed dose for 131I-targeted radiotherapy: a Monte Carlo study.
Saeedzadeh E; Sarkar S; Abbaspour Tehrani-Fard A; Ay MR; Khosravi HR; Loudos G
Radiat Prot Dosimetry; 2012 Jul; 150(3):298-305. PubMed ID: 22069233
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional personalized Monte Carlo dosimetry in 90Y resin microspheres therapy of hepatic metastases: nontumoral liver and lungs radiation protection considerations and treatment planning optimization.
Petitguillaume A; Bernardini M; Hadid L; de Labriolle-Vaylet C; Franck D; Desbrée A
J Nucl Med; 2014 Mar; 55(3):405-13. PubMed ID: 24504053
[TBL] [Abstract][Full Text] [Related]
3. Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation.
Dewaraja YK; Wilderman SJ; Ljungberg M; Koral KF; Zasadny K; Kaminiski MS
J Nucl Med; 2005 May; 46(5):840-9. PubMed ID: 15872359
[TBL] [Abstract][Full Text] [Related]
4. Implementation and evaluation of patient-specific three-dimensional internal dosimetry.
Kolbert KS; Sgouros G; Scott AM; Bronstein JE; Malane RA; Zhang J; Kalaigian H; McNamara S; Schwartz L; Larson SM
J Nucl Med; 1997 Feb; 38(2):301-8. PubMed ID: 9025759
[TBL] [Abstract][Full Text] [Related]
5. Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.
Sgouros G; Kolbert KS; Sheikh A; Pentlow KS; Mun EF; Barth A; Robbins RJ; Larson SM
J Nucl Med; 2004 Aug; 45(8):1366-72. PubMed ID: 15299063
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry.
Prideaux AR; Song H; Hobbs RF; He B; Frey EC; Ladenson PW; Wahl RL; Sgouros G
J Nucl Med; 2007 Jun; 48(6):1008-16. PubMed ID: 17504874
[TBL] [Abstract][Full Text] [Related]
7. Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90Y-microspheres.
Dieudonné A; Garin E; Laffont S; Rolland Y; Lebtahi R; Leguludec D; Gardin I
J Nucl Med; 2011 Dec; 52(12):1930-7. PubMed ID: 22068894
[TBL] [Abstract][Full Text] [Related]
8. Hepatic structural dosimetry in (90)Y microsphere treatment: a Monte Carlo modeling approach based on lobular microanatomy.
Gulec SA; Sztejnberg ML; Siegel JA; Jevremovic T; Stabin M
J Nucl Med; 2010 Feb; 51(2):301-10. PubMed ID: 20080888
[TBL] [Abstract][Full Text] [Related]
9. Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases.
Song H; He B; Prideaux A; Du Y; Frey E; Kasecamp W; Ladenson PW; Wahl RL; Sgouros G
J Nucl Med; 2006 Dec; 47(12):1985-94. PubMed ID: 17138741
[TBL] [Abstract][Full Text] [Related]
10. Monte Carlo and experimental internal radionuclide dosimetry in RANDO head phantom.
Ghahraman Asl R; Nasseri S; Parach AA; Zakavi SR; Momennezhad M; Davenport D
Australas Phys Eng Sci Med; 2015 Sep; 38(3):465-72. PubMed ID: 26232251
[TBL] [Abstract][Full Text] [Related]
11. A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.
Konijnenberg MW; Bijster M; Krenning EP; De Jong M
J Nucl Med; 2004 Jul; 45(7):1260-9. PubMed ID: 15235075
[TBL] [Abstract][Full Text] [Related]
12. Monte Carlo MCNP-4B-based absorbed dose distribution estimates for patient-specific dosimetry.
Yoriyaz H; Stabin MG; dos Santos A
J Nucl Med; 2001 Apr; 42(4):662-9. PubMed ID: 11337557
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I.
Pettinato C; Monari F; Nanni C; Allegri V; Marcatili S; Civollani S; Cima S; Spezi E; Mazzarotto R; Fanti S
Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):509-14. PubMed ID: 23358403
[TBL] [Abstract][Full Text] [Related]
14. Patient-specific dosimetry of conventional and intensity modulated radiation therapy using a novel full Monte Carlo phase space reconstruction method from electronic portal images.
Jarry G; Verhaegen F
Phys Med Biol; 2007 Apr; 52(8):2277-99. PubMed ID: 17404469
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the Application of Tissue-Specific Dose Kernels Instead of Water Dose Kernels in Internal Dosimetry: A Monte Carlo Study.
Khazaee Moghadam M; Kamali Asl A; Geramifar P; Zaidi H
Cancer Biother Radiopharm; 2016 Dec; 31(10):367-379. PubMed ID: 27996311
[TBL] [Abstract][Full Text] [Related]
16. On the need to revise the arm structure in stylized anthropomorphic phantoms in lateral photon irradiation geometry.
Lee C; Lee C; Lee JK
Phys Med Biol; 2006 Nov; 51(21):N393-402. PubMed ID: 17047258
[TBL] [Abstract][Full Text] [Related]
17. Development of a SPECT-based three-dimensional treatment planning system for radioimmunotherapy.
Giap HB; Macey DJ; Podoloff DA
J Nucl Med; 1995 Oct; 36(10):1885-94. PubMed ID: 7562060
[TBL] [Abstract][Full Text] [Related]
18. Monte Carlo calculations of absorbed doses in tumours using a modified MOBY mouse phantom for pre-clinical dosimetry studies.
Larsson E; Ljungberg M; Strand SE; Jönsson BA
Acta Oncol; 2011 Aug; 50(6):973-80. PubMed ID: 21767199
[TBL] [Abstract][Full Text] [Related]
19. MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee.
Bolch WE; Bouchet LG; Robertson JS; Wessels BW; Siegel JA; Howell RW; Erdi AK; Aydogan B; Costes S; Watson EE; Brill AB; Charkes ND; Fisher DR; Hays MT; Thomas SR
J Nucl Med; 1999 Jan; 40(1):11S-36S. PubMed ID: 9935083
[TBL] [Abstract][Full Text] [Related]
20. Monte Carlo treatment planning for molecular targeted radiotherapy within the MINERVA system.
Lehmann J; Hartmann Siantar C; Wessol DE; Wemple CA; Nigg D; Cogliati J; Daly T; Descalle MA; Flickinger T; Pletcher D; Denardo G
Phys Med Biol; 2005 Mar; 50(5):947-58. PubMed ID: 15798267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]